IMI 1st Call 2008

In accordance with the Council Regulation and the Statutes, the IMI Joint Undertaking (IMI JU) shall support prospective, pre-competitive pharmaceutical research and development, following open and competitive calls for project proposals, independent evaluation, and the conclusion of Grant Agreements and Project Agreements.

The projects implementing IMI Research Activities are to be funded jointly by the European Communities represented by the European Commission and by the research-based pharmaceutical companies that are members of EFPIA, the European Federation of Pharmaceutical Industries and Associations.

 

IMI Call Topics 2008

IMI Safety Pillar

1. Improve Predictivity of Immunogenicity

2. Non-genotoxic Carcinogenesis

3. Expert Systems for in silico Toxicity Prediction

4. Improved Predictivity of non-clinical Safety Evaluation

5. Qualification of Translational Safety Biomarkers

6. Strengthening the Monitoring of Benefit/Risk

 

IMI Efficacy Pillar

7. Islet Cell Research

8. Surrogate Markers for Vascular Endpoints

9. Pain Research

10. New Tools for the Development of Novel Therapies in Psychiatric Disorders

11. Neurodegenerative Disorders

12. Understanding Severe Asthma

13. COPD Patient Reported Outcomes

 

IMI Education & Training Pillar

14. European Medicines Research Training Network

15. Safety Sciences for Medicines Training Programme

16. Pharmaceutical Medicine Training Programme

17. Integrated Medicines Development Programme

18. Pharmacovigilance Training Programme

 

IMI Calls for Proposals are conducted through a 2-stage process:

The first stage of the call process is addressing 'Applicant Consortia' (e.g. collaborations between academia, SMEs, patient organisations, non EFPIA industry, etc), to submit to the IMI JU an Expression of Interest in response to a call.

Please note: Submission of an Expression of Interest is the first step in the IMI Call/evaluation procedure and does not imply any funding commitment from the IMI Joint Undertaking.

 

In the second stage, following the first stage peer review, the 'Applicant Consortium' of the best Expression of Interest, and the 'EFPIA consortium' that already are associated to the topic, will be invited to form a full 'Project Consortium'. The full project proposal shall contain a draft Project Agreement which is to be concluded between all members of the consortium governing their relationship, including detailed intellectual property rights based on the IMI JU intellectual property rights policy.

The Full project proposals will be evaluated based on consistency with the original Expression of Interest, on scientific excellence, the quality of the implementation plan and the potential impact. Ethical issues will be considered at this stage.

 

Only Full project proposals that have been favourably reviewed in the evaluation process can be selected for funding. These will be invited to conclude a Grant Agreement governing the relationship between the selected project consortium and the IMI JU.

 

Budget:

• a maximum financial contribution from the European Community to the IMI JU for the support of research activities of €122.7 million, subject to confirmation following the adoption of the Amending Budget 3/2008 and
• an indicative in-kind contribution by the research based companies that are members of EFPIA of € 172.5 million

 

Deadline for submission of EoIs: 15 July 2008 at 17:00:00 (Brussels local time)

 

More information: http://imi.europa.eu/calls-01_en.html